Rudolf-Boehm-Institute for Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany;
Biochemia Pharmacological Institute/bpc, Philipps-University Marburg, Marburg, Germany
Rudolf-Boehm-Institute for Pharmacology and Toxicology, Uni-versity of Leipzig, Leipzig, Germany;
Biochemia Pharmacological Institute/bpc, Philipps-University Marburg, Marburg, Germany;
Present Address: Targos Molecular Pathology GmbH, Kassel, Germany
Rudolf-Boehm-Institute for Pharmacology and Toxicology, Uni-versity of Leipzig, Leipzig, Germany;
Biochemia Pharmacological Institute/bpc, Philipps-University Marburg, Marburg, Germany;
Present Address: Institute for Immunology, Philipps-University Marburg, Marburg, German
Walther Straub Institute of Pharmacology and Toxicology, University of Munich (LMU), Munich, Germany;
Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research, Munich, Germany
Rudolf-Boehm-Institute for Pharmacology and Toxicology, Uni-versity of Leipzig, Leipzig, Germany;
Biochemia Pharmacological Institute/bpc, Philipps-University Marburg, Marburg, Germany
Copyright © 2014 Thomas R. H. Büch, Marius Grzelinski, Olaf Pinkenburg, Thomas Gudermann, Achim Aigner et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Büch, T. , Grzelinski, M. , Pinkenburg, O. , Gudermann, T. and Aigner, A. (2014) Cell-type specific and non-redundant anti-proliferative effects of shRNA-mediated Galpha12- and Galpha13 knockdown in lung cancer cell lines.
Advances in Bioscience and Biotechnology,
5, 73-80. doi:
10.4236/abb.2014.51011.